IBTA News

Ibotta’s 2026 State of Spend Report Reveals 62% of Shoppers Now Choose Price Over Brand, Shaping How CPG Brands Drive Trial and Loyalty

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ibotta, Inc. (IBTA) And Encourages Investors to Reach Out

Ibotta, Inc. (IBTA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Ibotta, Inc. (IBTA) Shareholders to Inquire about Securities Investigation

Ibotta To Announce Fourth Quarter 2025 Financial Results on February 25, 2026

Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf

Bronstein, Gewirtz & Grossman, LLC Is Investigating Ibotta, Inc. (IBTA) And Encourages Shareholders to Connect

Notice to Long-Term Shareholders of CoreWeave, Inc. (NASDAQ: CRWV); Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ibotta, Inc. (IBTA) And Encourages Shareholders to Reach Out

Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf